Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
53,888,889
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
35,239,863
-
Shares change
-
-453,441
-
Total reported value, excl. options
-
$267,821,748
-
Value change
-
-$5,157,565
-
Put/Call ratio
-
24%
-
Number of buys
-
17
-
Number of sells
-
13
-
Price
-
$7.60
Institutional Holders of Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) as of Q4 2022
49 filings reported holding TYRA - Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share as of 31 Dec 2022.
Tyra Biosciences, Inc. - Common Stock, par value $0.0001 per share (TYRA) had 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 35,239,863 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Boxer Capital, LLC, Canaan Partners XI LLC, FMR LLC, Nextech Invest Ltd., BVF INC/IL, TCG Crossover Management, LLC, Fairmount Funds Management LLC, Frazier Life Sciences Management, L.P., and BlackRock Inc..
This table shows the top 45 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.